Earlier this month, the FDA put out a statement saying that it, too, was concerned about patients and healthcare professionals turning to unapproved versions of GLP-1 drugs as an option for weight ...
The initial order, valued at ₹4,099 Crore, covered similar services for the Middle Mile Network in Karnataka, Goa, and Puducherry.